EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Meet the Contributors →

C4 Therapeutics Names Broad Institute’s Phillips CSO

Ben Fidler

February 2nd, 2016

Xconomy Boston — 

Cambridge, MA-based C4 Therapeutics has named Andrew Phillips its chief scientific officer. Phillips was most recently an executive at the Broad Institute of MIT and Harvard, where he headed development of therapeutics. He was a chemistry professor at Yale University before that.

Ben Fidler is Xconomy's Deputy Editor, Biotechnology. You can e-mail him at bfidler@xconomy.com Follow @benthefidler

More from EXOME

Trending on Xconomy

The Feed

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.

© 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.